{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T15:40:54Z","timestamp":1776613254613,"version":"3.51.2"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["BT\/COE\/34\/SP15097\/2015"],"award-info":[{"award-number":["BT\/COE\/34\/SP15097\/2015"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.bbrc.2026.153536","type":"journal-article","created":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T15:46:00Z","timestamp":1772207160000},"page":"153536","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Cytokine expression mediated immunogenic response of therapeutic IgG aggregates obtained by forced degradative stress factors and the role of a deep neural network in its prediction"],"prefix":"10.1016","volume":"811","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8561-4797","authenticated-orcid":false,"given":"Rozaleen","family":"Dash","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shravan","family":"Sreenivasan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9646-1554","authenticated-orcid":false,"given":"Anandi","family":"Chowdhury","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naveen G.","family":"Jesubalan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Narendra","family":"Chirmule","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zuben E.","family":"Sauna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5913-4244","authenticated-orcid":false,"given":"Anurag S.","family":"Rathore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.bbrc.2026.153536_bib1","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1002\/jps.21530","article-title":"Overlooking subvisible particles in therapeutic protein products: gaps that may compromise product quality","volume":"98","author":"Carpenter","year":"2009","journal-title":"J. Pharmaceut. Sci."},{"issue":"4","key":"10.1016\/j.bbrc.2026.153536_bib2","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1007\/s11095-014-1541-x","article-title":"Small amounts of sub-visible aggregates enhance the immunogenic potential of monoclonal antibody therapeutics","volume":"32","author":"Ahmadi","year":"2015","journal-title":"Pharm. Res."},{"issue":"5","key":"10.1016\/j.bbrc.2026.153536_bib3","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1002\/jps.24379","article-title":"Physical characterization and in vitro biological impact of highly aggregated antibodies separated into size-enriched populations by fluorescence-activated cell sorting","volume":"104","author":"Telikepalli","year":"2015","journal-title":"J. Pharmaceut. Sci."},{"issue":"9","key":"10.1016\/j.bbrc.2026.153536_bib4","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1002\/biot.201400052","article-title":"Avoiding antibody aggregation during processing: establishing hold times","volume":"9","author":"Joshi","year":"2014","journal-title":"Biotechnol. J."},{"issue":"4","key":"10.1016\/j.bbrc.2026.153536_bib5","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1007\/s11095-010-0297-1","article-title":"Strategies for the assessment of protein aggregates in pharmaceutical biotech product development","volume":"28","author":"den Engelsman","year":"2011","journal-title":"Pharm. Res."},{"issue":"3","key":"10.1016\/j.bbrc.2026.153536_bib6","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1208\/s12248-016-9887-0","article-title":"Aggregation kinetics for IgG1-Based monoclonal antibody therapeutics","volume":"18","author":"Singla","year":"2016","journal-title":"AAPS J."},{"issue":"3","key":"10.1016\/j.bbrc.2026.153536_bib7","doi-asserted-by":"crossref","first-page":"E501","DOI":"10.1208\/aapsj080359","article-title":"Effects of protein aggregates: an immunologic perspective","volume":"8","author":"Rosenberg","year":"2006","journal-title":"AAPS J."},{"key":"10.1016\/j.bbrc.2026.153536_bib9","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1034\/j.1600-065X.2000.00607.x","article-title":"B-cell activation by T-cell-independent type 2 antigens as an integral part of the humoral immune response to pathogenic microorganisms","volume":"176","author":"Vos","year":"2000","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.bbrc.2026.153536_bib10","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/9259646","article-title":"Biologics for targeting inflammatory cytokines, clinical uses, and limitations","volume":"2016","author":"Rider","year":"2016","journal-title":"Int. J. Cell Biol."},{"issue":"28","key":"10.1016\/j.bbrc.2026.153536_bib11","doi-asserted-by":"crossref","first-page":"25118","DOI":"10.1074\/jbc.M110.160457","article-title":"Classification and characterization of therapeutic antibody aggregates","volume":"286","author":"Joubert","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"11","key":"10.1016\/j.bbrc.2026.153536_bib12","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1016\/j.bbamcr.2014.05.014","article-title":"Cytokines and chemokines: at the crossroads of cell signalling and inflammatory disease","volume":"1843","author":"Turner","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbrc.2026.153536_bib13","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.3389\/fimmu.2020.01301","article-title":"T-Cell dependent immunogenicity of protein therapeutics pre-clinical assessment and mitigation-updated consensus and review 2020","volume":"11","author":"Jawa","year":"2020","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.bbrc.2026.153536_bib14","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1002\/jps.21521","article-title":"Principles, approaches, and challenges for predicting protein aggregation rates and shelf life","volume":"98","author":"Weiss","year":"2009","journal-title":"J. Pharmaceut. Sci."},{"issue":"2","key":"10.1016\/j.bbrc.2026.153536_bib15","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1002\/jps.22276","article-title":"Impact of product-related factors on immunogenicity of biotherapeutics","volume":"100","author":"Singh","year":"2011","journal-title":"J. Pharmaceut. Sci."},{"issue":"6","key":"10.1016\/j.bbrc.2026.153536_bib16","doi-asserted-by":"crossref","first-page":"740","DOI":"10.4161\/mabs.22066","article-title":"Immunogenicity of different stressed IgG monoclonal antibody formulations in immune tolerant transgenic mice","volume":"4","author":"Filipe","year":"2012","journal-title":"mAbs"},{"issue":"10","key":"10.1016\/j.bbrc.2026.153536_bib17","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1007\/s11095-021-03108-7","article-title":"Image analysis algorithm-based platform for determining micron and higher aggregate size distribution of therapeutic IgG using brightfield and fluorescence microscope images","volume":"38","author":"Sreenivasan","year":"2021","journal-title":"Pharm. Res."},{"issue":"6","key":"10.1016\/j.bbrc.2026.153536_bib18","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1021\/acs.molpharmaceut.3c00051","article-title":"Combined presence of ferrous ions and hydrogen peroxide in normal saline and in vitro models induces enhanced aggregation of therapeutic IgG due to hydroxyl radicals","volume":"20","author":"Sreenivasan","year":"2023","journal-title":"Mol. Pharm."},{"issue":"10","key":"10.1016\/j.bbrc.2026.153536_bib19","doi-asserted-by":"crossref","first-page":"4347","DOI":"10.1002\/jps.21328","article-title":"Shaken, not stirred: mechanical stress testing of an IgG1 antibody","volume":"97","author":"Kiese","year":"2008","journal-title":"J. Pharmaceut. Sci."},{"key":"10.1016\/j.bbrc.2026.153536_bib20","doi-asserted-by":"crossref","first-page":"4538","DOI":"10.1016\/j.csbj.2021.08.011","article-title":"A review on machine learning approaches and trends in drug discovery","volume":"19","author":"Carracedo-Reboredo","year":"2021","journal-title":"Comput. Struct. Biotechnol. J."},{"issue":"22","key":"10.1016\/j.bbrc.2026.153536_bib21","doi-asserted-by":"crossref","first-page":"5277","DOI":"10.3390\/molecules25225277","article-title":"Machine learning methods in drug discovery","volume":"25","author":"Patel","year":"2020","journal-title":"Molecules (Basel, Switzerland)"},{"issue":"5","key":"10.1016\/j.bbrc.2026.153536_bib22","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.coph.2008.08.002","article-title":"Prediction of immunogenicity: in silico paradigms, ex vivo and in vivo correlates","volume":"8","author":"De Groot","year":"2008","journal-title":"Curr. Opin. Pharmacol."},{"issue":"1","key":"10.1016\/j.bbrc.2026.153536_bib23","doi-asserted-by":"crossref","first-page":"3703","DOI":"10.1038\/s41467-022-31535-6","article-title":"Network-based machine learning approach to predict immunotherapy response in cancer patients","volume":"13","author":"Kong","year":"2022","journal-title":"Nat. Commun."},{"issue":"17","key":"10.1016\/j.bbrc.2026.153536_bib24","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.4155\/bio-2018-0246","article-title":"Nonclinical immunogenicity risk assessment of therapeutic proteins","volume":"11","author":"Tourdot","year":"2019","journal-title":"Bioanalysis"},{"issue":"5","key":"10.1016\/j.bbrc.2026.153536_bib25","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1111\/jphp.12810","article-title":"Immunogenicity assessment during the development of protein therapeutics","volume":"70","author":"Rosenberg","year":"2018","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.bbrc.2026.153536_bib26","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.ejpb.2021.08.010","article-title":"Rapid aggregation of therapeutic monoclonal antibodies by bubbling induced air\/liquid interfacial and agitation stress at different conditions","volume":"168","author":"Sreenivasan","year":"2021","journal-title":"Eur. J. Pharm. Biopharm. : Offic. J. Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V"},{"issue":"2","key":"10.1016\/j.bbrc.2026.153536_bib27","doi-asserted-by":"crossref","DOI":"10.21769\/BioProtoc.2103","article-title":"Isolation of peripheral blood mononuclear cells using vacutainer\u00ae cellular preparation tubes (CPTTM)","volume":"7","author":"Puleo","year":"2017","journal-title":"Bio-Protocol"},{"key":"10.1016\/j.bbrc.2026.153536_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-4939-9728-2_1","article-title":"Flow cytometry analysis to identify human CD8+ T cells","volume":"2048","author":"Flynn","year":"2019","journal-title":"Methods Mol. Biol."},{"issue":"4-5","key":"10.1016\/j.bbrc.2026.153536_bib29","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.cyto.2004.04.003","article-title":"Comparison of results using the gel microdrop cytokine secretion assay with ELISPOT and intracellular cytokine staining assay","volume":"27","author":"Atochina","year":"2004","journal-title":"Cytokine"},{"issue":"1-2","key":"10.1016\/j.bbrc.2026.153536_bib30","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jim.2007.11.004","article-title":"Performance evaluation of cytometric bead assays for the measurement of lung cytokines in two rodent models","volume":"331","author":"Young","year":"2008","journal-title":"J. Immunol. Methods"},{"issue":"2","key":"10.1016\/j.bbrc.2026.153536_bib31","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1373\/clinchem.2009.135087","article-title":"Comparison of multiplex immunoassay platforms","volume":"56","author":"Fu","year":"2010","journal-title":"Clin. Chem."},{"issue":"2","key":"10.1016\/j.bbrc.2026.153536_bib32","first-page":"172","article-title":"Immunogenicity of therapeutic monoclonal antibodies","volume":"5","author":"Pendley","year":"2003","journal-title":"Curr. Opin. Mol. Therapeut."},{"issue":"4","key":"10.1016\/j.bbrc.2026.153536_bib33","first-page":"250","article-title":"Monoclonal antibodies, immunogenicity, and associated infusion reactions","volume":"72","author":"Cheifetz","year":"2005","journal-title":"MSJM (Mt. Sinai J. Med.)"},{"issue":"1","key":"10.1016\/j.bbrc.2026.153536_bib34","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.clim.2010.06.018","article-title":"Considerations for optimization and validation of an in vitro PBMC derived T cell assay for immunogenicity prediction of biotherapeutics","volume":"137","author":"Wullner","year":"2010","journal-title":"Clin. Immunol."},{"issue":"4","key":"10.1016\/j.bbrc.2026.153536_bib35","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/0016-5085(92)91519-A","article-title":"Immunoglobulin A and interleukin 6 form a positive secretory feedback loop: a study of normal subjects and alcoholic cirrhotics","volume":"103","author":"Deviere","year":"1992","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbrc.2026.153536_bib36","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.cellimm.2017.12.010","article-title":"MIF promotes a differential Th1\/Th2\/Th17 inflammatory response in human primary cell cultures: predominance of Th17 cytokine profile in PBMC from healthy subjects and increase of IL-6 and TNF-\u03b1 in PBMC from active SLE patients","volume":"324","author":"De la Cruz-Mosso","year":"2018","journal-title":"Cell. Immunol."},{"issue":"18","key":"10.1016\/j.bbrc.2026.153536_bib37","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/S0161-5890(01)00025-6","article-title":"Role of natural and immune IgM antibodies in immune responses","volume":"37","author":"Boes","year":"2000","journal-title":"Mol. Immunol."},{"issue":"7","key":"10.1016\/j.bbrc.2026.153536_bib38","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/nrrheum.2011.76","article-title":"Anti-CCP antibodies: the past, the present and the future","volume":"7","author":"van Venrooij","year":"2011","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.bbrc.2026.153536_bib39","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.802934","article-title":"Anti-citrullinated protein antibody generation, pathogenesis, clinical application, and prospects","volume":"8","author":"Liu","year":"2022","journal-title":"Front. Med."},{"issue":"2","key":"10.1016\/j.bbrc.2026.153536_bib40","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.xphs.2015.11.002","article-title":"Immunogenicity of therapeutic protein aggregates","volume":"105","author":"Moussa","year":"2016","journal-title":"J. Pharmaceut. Sci."},{"issue":"9","key":"10.1016\/j.bbrc.2026.153536_bib41","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1002\/jps.21566","article-title":"Protein aggregation: pathways, induction factors and analysis","volume":"98","author":"Mahler","year":"2009","journal-title":"J. Pharmaceut. Sci."},{"issue":"2","key":"10.1016\/j.bbrc.2026.153536_bib42","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ijpharm.2010.02.025","article-title":"Protein aggregation--pathways and influencing factors","volume":"390","author":"Wang","year":"2010","journal-title":"Int. J. Pharm."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X26003001?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X26003001?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T14:51:09Z","timestamp":1776610269000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X26003001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":41,"alternative-id":["S0006291X26003001"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.153536","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cytokine expression mediated immunogenic response of therapeutic IgG aggregates obtained by forced degradative stress factors and the role of a deep neural network in its prediction","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.153536","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"153536"}}